World Health Organization (WHO) International Classification of Functioning, Disability and Health (ICF) Core Set Development for Interstitial Lung Disease

By sjmartinez • November 1, 2022

Saketkoo LA, Escorpizo R, Varga J, Keen KJ, Fligelstone K, Birring SS, Alexanderson H, Pettersson H, Chaudhry HA, Poole JL, Regardt M, LeSage D, Sarver C, Lanario J, Renzoni E, Scholand MB, Lammi MR, Kowal-Bielecka O, Distler O, Frech T, Shapiro L, Varju C, Volkmann ER, Bernstein EJ, Drent M, Obi ON, Patterson KC, Russell AM; Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis (G-FoRSS). World Health Organization (WHO) International Classification of Functioning, Disability and Health (ICF) Core Set Development for Interstitial Lung Disease. Front Pharmacol. 2022 Oct 14;13:979788. doi: 10.3389/fphar.2022.979788. PMID: 36313333; PMCID: PMC9615472.

Tags: connective tissue, cough, CTD-ILD;, fibrosis, ICD-11, patient-reported outcomes, Publications, Rheumatology

Efficacy and safety of daprodustat in patients on peritoneal dialysis in the ASCEND-D trial

Dasgupta I, Meadowcroft AM, Bhatt PR, Acharya A, Aarup M, Correa-Rotter R, Gupta S, Kher VK, Neto OMV, Rastogi A, Ots-Rosenberg M, Rayner B, Wong[...]

Insulin-producing cells derived from expandable stem cell-derived endoderm are effective for the treatment of type 2 diabetes

Yoshihara E. Insulin-producing cells derived from expandable stem cell-derived endoderm are effective for the treatment of type 2 diabetes. Ann Transl Med. 2024 Dec 24;12(6):121.[...]

Sodium-Glucose Cotransporter 2 Inhibitor Use and Outcomes in Transthyretin Amyloid Cardiomyopathy

Jaiswal V, Hanif M, Mashkoor Y, Jaiswal A, Prasad T, Rajak K, Khan MS, Mentz RJ, Fonarow GC. Sodium-Glucose Cotransporter 2 Inhibitor Use and Outcomes[...]